Minimal Vitrectomy Surgery for Epiretinal Membrane

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This multicenter randomized controlled trial evaluates Minimal Vitrectomy Surgery (MVS) versus conventional vitrectomy for idiopathic epiretinal membrane (ERM). The primary endpoints include visual acuity improvement and cataract progression after 12 months. MVS aims to minimize vitreous removal while ensuring complete membrane removal through adaptive limited vitrectomy.
Epistemonikos ID: e5106f6f9c9797a8d667384e86e1388c64b2e9b7
First added on: Jun 14, 2025